DIFFERENCES IN BRAIN-METABOLITES BETWEEN PATIENTS WITH AUTISM AND MENTAL-RETARDATION AS DETECTED BY IN-VIVO LOCALIZED PROTON MAGNETIC-RESONANCE SPECTROSCOPY
T. Hashimoto et al., DIFFERENCES IN BRAIN-METABOLITES BETWEEN PATIENTS WITH AUTISM AND MENTAL-RETARDATION AS DETECTED BY IN-VIVO LOCALIZED PROTON MAGNETIC-RESONANCE SPECTROSCOPY, Journal of child neurology, 12(2), 1997, pp. 91-96
We performed volume-selective proton magnetic resonance spectroscopy (
H-1-MRS) of the brain with a 1.5 T magnet in 28 patients with autism,
and compared the results with those from 28 age-matched patients with
unclassified mental retardation and 25 age-matched healthy children. P
eaks for N-acetylaspartate, choline and creatine, but not lactate, wer
e observed in each group on H-1-MRS. The N-acetylaspartate/choline rat
io was lower in patients with mental retardation than in patients with
autism and controls (P = .05, respectively). However, there were no d
ifferences in the N-acetylaspartate/choline ratios between patients wi
th autism and controls, and the N-acetylaspartate/creatine and choline
/creatine ratios did not differ among the three groups. These results
suggest that N-acetylaspartate is decreased in patients with mental re
tardation and that a disorder or dysfunction of neurons in the brain e
xists. There also appear to be differences in the brain lesions or dys
functions found in patients with autism and mental retardation.